Proactiveinvestors USA & Canada ImmunoPrecise Antibodies Ltd https://www.proactiveinvestors.com Proactiveinvestors USA & Canada ImmunoPrecise Antibodies Ltd RSS feed en Mon, 13 Jul 2020 10:42:38 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) ImmunoPrecise Antibodies wins US$75K grant from North Dakota to fund coronavirus treatments https://www.proactiveinvestors.com/companies/news/918100/immunoprecise-antibodies-wins-us75k-grant-from-north-dakota-to-fund-coronavirus-treatments-918100.html Fri, 24 Apr 2020 18:49:00 -0400 https://www.proactiveinvestors.com/companies/news/918100/immunoprecise-antibodies-wins-us75k-grant-from-north-dakota-to-fund-coronavirus-treatments-918100.html NA Proactive news snapshot: Bevcanna Enterprises, Globex Mining Enterprises, Telson Mining, Milestone Scientific, Bay Talent Group, Energy Fuels UPDATE ... https://www.proactiveinvestors.com/companies/news/917537/na-proactive-news-snapshot-bevcanna-enterprises-globex-mining-enterprises-telson-mining-milestone-scientific-bay-talent-group-energy-fuels-update--917537.html Fri, 17 Apr 2020 20:05:00 -0400 https://www.proactiveinvestors.com/companies/news/917537/na-proactive-news-snapshot-bevcanna-enterprises-globex-mining-enterprises-telson-mining-milestone-scientific-bay-talent-group-energy-fuels-update--917537.html ImmunoPrecise Antibodies says coronavirus research activities for experimental vaccines and therapeutics advancing https://www.proactiveinvestors.com/companies/news/917531/immunoprecise-antibodies-says-coronavirus-research-activities-for-experimental-vaccines-and-therapeutics-advancing-917531.html Fri, 17 Apr 2020 13:25:00 -0400 https://www.proactiveinvestors.com/companies/news/917531/immunoprecise-antibodies-says-coronavirus-research-activities-for-experimental-vaccines-and-therapeutics-advancing-917531.html ImmunoPrecise Antibodies says subsidiary Talem Therapeutics enters research license agreement with Janssen Research & Development https://www.proactiveinvestors.com/companies/news/917192/immunoprecise-antibodies-says-subsidiary-talem-therapeutics-enters-research-license-agreement-with-janssen-research--development-917192.html Tue, 14 Apr 2020 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/917192/immunoprecise-antibodies-says-subsidiary-talem-therapeutics-enters-research-license-agreement-with-janssen-research--development-917192.html ImmunoPrecise Antibodies names Yasmina Noubia Abdiche as chief scientific officer https://www.proactiveinvestors.com/companies/news/916503/immunoprecise-antibodies-names-yasmina-noubia-abdiche-as-chief-scientific-officer-916503.html Thu, 02 Apr 2020 13:40:00 -0400 https://www.proactiveinvestors.com/companies/news/916503/immunoprecise-antibodies-names-yasmina-noubia-abdiche-as-chief-scientific-officer-916503.html ImmunoPrecise Antibodies and its AI collaborator team up on research program to help fight coronavirus https://www.proactiveinvestors.com/companies/news/916160/immunoprecise-antibodies-and-its-ai-collaborator-team-up-on-research-program-to-help-fight-coronavirus-916160.html Mon, 30 Mar 2020 21:03:00 -0400 https://www.proactiveinvestors.com/companies/news/916160/immunoprecise-antibodies-and-its-ai-collaborator-team-up-on-research-program-to-help-fight-coronavirus-916160.html NA Proactive news snapshot: Marrone Bio, Silvercorp Metals, Ascent Industries, Golden Arrow Resources UPDATE … https://www.proactiveinvestors.com/companies/news/914854/na-proactive-news-snapshot-marrone-bio-silvercorp-metals-ascent-industries-golden-arrow-resources-update--914854.html Thu, 12 Mar 2020 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/914854/na-proactive-news-snapshot-marrone-bio-silvercorp-metals-ascent-industries-golden-arrow-resources-update--914854.html ImmunoPrecise Antibodies unveils new therapy approach in bid to tackle coronavirus https://www.proactiveinvestors.com/companies/news/914841/immunoprecise-antibodies-unveils-new-therapy-approach-in-bid-to-tackle-coronavirus-914841.html Thu, 12 Mar 2020 17:23:00 -0400 https://www.proactiveinvestors.com/companies/news/914841/immunoprecise-antibodies-unveils-new-therapy-approach-in-bid-to-tackle-coronavirus-914841.html ImmunoPrecise Antibodies shares lifted as it reports positive adjusted underlying earnings for 3Q and nine months https://www.proactiveinvestors.com/companies/news/914669/immunoprecise-antibodies-shares-lifted-as-it-reports-positive-adjusted-underlying-earnings-for-3q-and-nine-months-914669.html Tue, 10 Mar 2020 17:35:00 -0400 https://www.proactiveinvestors.com/companies/news/914669/immunoprecise-antibodies-shares-lifted-as-it-reports-positive-adjusted-underlying-earnings-for-3q-and-nine-months-914669.html ImmunoPrecise forges AI collaboration with EVQLV to discover vaccine and antibodies for coronavirus https://www.proactiveinvestors.com/companies/news/914072/immunoprecise-forges-ai-collaboration-with-evqlv-to-discover-vaccine-and-antibodies-for-coronavirus-914072.html Mon, 02 Mar 2020 15:00:00 -0500 https://www.proactiveinvestors.com/companies/news/914072/immunoprecise-forges-ai-collaboration-with-evqlv-to-discover-vaccine-and-antibodies-for-coronavirus-914072.html ImmunoPrecise Antibodies joins global fight against coronavirus https://www.proactiveinvestors.com/companies/news/913375/immunoprecise-antibodies-joins-global-fight-against-coronavirus-913375.html Thu, 20 Feb 2020 20:23:00 -0500 https://www.proactiveinvestors.com/companies/news/913375/immunoprecise-antibodies-joins-global-fight-against-coronavirus-913375.html ImmunoPrecise Antibodies bolsters its capability at European operations with automated DNA printer https://www.proactiveinvestors.com/companies/news/911041/immunoprecise-antibodies-bolsters-its-capability-at-european-operations-with-automated-dna-printer-911041.html Mon, 20 Jan 2020 14:26:00 -0500 https://www.proactiveinvestors.com/companies/news/911041/immunoprecise-antibodies-bolsters-its-capability-at-european-operations-with-automated-dna-printer-911041.html ImmunoPrecise Antibodies' Dutch subsidiary to take up new home at Europe's most competitive science region https://www.proactiveinvestors.com/companies/news/910295/immunoprecise-antibodies--dutch-subsidiary-to-take-up-new-home-at-europe-s-most-competitive-science-region-910295.html Thu, 09 Jan 2020 15:05:00 -0500 https://www.proactiveinvestors.com/companies/news/910295/immunoprecise-antibodies--dutch-subsidiary-to-take-up-new-home-at-europe-s-most-competitive-science-region-910295.html ImmunoPrecise Antibodies boosts 2Q revenue on the back of higher-value clients and contracts https://www.proactiveinvestors.com/companies/news/909393/immunoprecise-antibodies-boosts-2q-revenue-on-the-back-of-higher-value-clients-and-contracts-909393.html Tue, 17 Dec 2019 15:40:00 -0500 https://www.proactiveinvestors.com/companies/news/909393/immunoprecise-antibodies-boosts-2q-revenue-on-the-back-of-higher-value-clients-and-contracts-909393.html ImmunoPrecise Antibodies is expanding its therapeutic offerings as a global full-service antibody provider https://www.proactiveinvestors.com/companies/news/908604/immunoprecise-antibodies-is-expanding-its-therapeutic-offerings-as-a-global-full-service-antibody-provider-908604.html Fri, 06 Dec 2019 06:00:00 -0500 https://www.proactiveinvestors.com/companies/news/908604/immunoprecise-antibodies-is-expanding-its-therapeutic-offerings-as-a-global-full-service-antibody-provider-908604.html ImmunoPrecise Antibodies subsidiary Talem Therapeutics inks deal with Ligand Pharmaceuticals for OmniAb platform https://www.proactiveinvestors.com/companies/news/906370/immunoprecise-antibodies-subsidiary-talem-therapeutics-inks-deal-with-ligand-pharmaceuticals-for-omniab-platform-906370.html Tue, 05 Nov 2019 21:39:00 -0500 https://www.proactiveinvestors.com/companies/news/906370/immunoprecise-antibodies-subsidiary-talem-therapeutics-inks-deal-with-ligand-pharmaceuticals-for-omniab-platform-906370.html ImmunoPrecise Antibodies appoints industry veteran Brian Lundstrom to its board https://www.proactiveinvestors.com/companies/news/904110/immunoprecise-antibodies-appoints-industry-veteran-brian-lundstrom-to-its-board-904110.html Thu, 03 Oct 2019 13:40:00 -0400 https://www.proactiveinvestors.com/companies/news/904110/immunoprecise-antibodies-appoints-industry-veteran-brian-lundstrom-to-its-board-904110.html ImmunoPrecise Antibodies adds biotechnology executive Dr Stefan Lang as chief business officer https://www.proactiveinvestors.com/companies/news/903916/immunoprecise-antibodies-adds-biotechnology-executive-dr-stefan-lang-as-chief-business-officer-903916.html Tue, 01 Oct 2019 15:25:00 -0400 https://www.proactiveinvestors.com/companies/news/903916/immunoprecise-antibodies-adds-biotechnology-executive-dr-stefan-lang-as-chief-business-officer-903916.html ImmunoPrecise Antibodies aiming to enhance value of its IP; reports debenture extension https://www.proactiveinvestors.com/companies/news/903785/immunoprecise-antibodies-aiming-to-enhance-value-of-its-ip-reports-debenture-extension-903785.html Mon, 30 Sep 2019 13:30:00 -0400 https://www.proactiveinvestors.com/companies/news/903785/immunoprecise-antibodies-aiming-to-enhance-value-of-its-ip-reports-debenture-extension-903785.html ImmunoPrecise subsidiary Talem enters into JV with biopharma company AgonOx https://www.proactiveinvestors.com/companies/news/903360/immunoprecise-subsidiary-talem-enters-into-jv-with-biopharma-company-agonox-903360.html Tue, 24 Sep 2019 13:50:00 -0400 https://www.proactiveinvestors.com/companies/news/903360/immunoprecise-subsidiary-talem-enters-into-jv-with-biopharma-company-agonox-903360.html ImmunoPrecise Antibodies unveils antibody-engineering platform Abthena https://www.proactiveinvestors.com/companies/news/903269/immunoprecise-antibodies-unveils-antibody-engineering-platform-abthena-903269.html Mon, 23 Sep 2019 15:15:00 -0400 https://www.proactiveinvestors.com/companies/news/903269/immunoprecise-antibodies-unveils-antibody-engineering-platform-abthena-903269.html ImmunoPrecise reports record fiscal full-year revenue following European expansion https://www.proactiveinvestors.com/companies/news/901730/immunoprecise-reports-record-fiscal-full-year-revenue-following-european-expansion-901730.html Thu, 29 Aug 2019 14:11:00 -0400 https://www.proactiveinvestors.com/companies/news/901730/immunoprecise-reports-record-fiscal-full-year-revenue-following-european-expansion-901730.html ImmunoPrecise Antibodies expecting significant revenue growth in 2019 https://www.proactiveinvestors.com/companies/news/900461/immunoprecise-antibodies-expecting-significant-revenue-growth-in-2019-900461.html Fri, 09 Aug 2019 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/900461/immunoprecise-antibodies-expecting-significant-revenue-growth-in-2019-900461.html ImmunoPrecise subsidiary Talem Therapeutics forms scientific advisory committee https://www.proactiveinvestors.com/companies/news/224867/immunoprecise-subsidiary-talem-therapeutics-forms-scientific-advisory-committee-224867.html Thu, 01 Aug 2019 13:10:00 -0400 https://www.proactiveinvestors.com/companies/news/224867/immunoprecise-subsidiary-talem-therapeutics-forms-scientific-advisory-committee-224867.html ImmunoPrecise inks new agreement to use proprietary screening platform in cancer therapy https://www.proactiveinvestors.com/companies/news/223922/immunoprecise-inks-new-agreement-to-use-proprietary-screening-platform-in-cancer-therapy-223922.html Mon, 15 Jul 2019 16:16:00 -0400 https://www.proactiveinvestors.com/companies/news/223922/immunoprecise-inks-new-agreement-to-use-proprietary-screening-platform-in-cancer-therapy-223922.html ImmunoPrecise guarantees success rate of its B cell Select Antibody Discovery Platform https://www.proactiveinvestors.com/companies/news/222870/immunoprecise-guarantees-success-rate-of-its-b-cell-select-antibody-discovery-platform-222870.html Wed, 26 Jun 2019 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/222870/immunoprecise-guarantees-success-rate-of-its-b-cell-select-antibody-discovery-platform-222870.html ImmunoPrecise signs up a slew of new pharma clients for its antibody-discovering phage display platform https://www.proactiveinvestors.com/companies/news/221234/immunoprecise-signs-up-a-slew-of-new-pharma-clients-for-its-antibody-discovering-phage-display-platform-221234.html Thu, 30 May 2019 19:30:00 -0400 https://www.proactiveinvestors.com/companies/news/221234/immunoprecise-signs-up-a-slew-of-new-pharma-clients-for-its-antibody-discovering-phage-display-platform-221234.html ImmunoPrecise subsidiary U-Protein Express clinches license from Stanford University to manufacture protein https://www.proactiveinvestors.com/companies/news/219120/immunoprecise-subsidiary-u-protein-express-clinches-license-from-stanford-university-to-manufacture-protein-219120.html Thu, 25 Apr 2019 13:42:00 -0400 https://www.proactiveinvestors.com/companies/news/219120/immunoprecise-subsidiary-u-protein-express-clinches-license-from-stanford-university-to-manufacture-protein-219120.html ImmunoPrecise Antibodies recruits pharma exec Andy Nixon to board https://www.proactiveinvestors.com/companies/news/218433/immunoprecise-antibodies-recruits-pharma-exec-andy-nixon-to-board-218433.html Thu, 11 Apr 2019 13:55:00 -0400 https://www.proactiveinvestors.com/companies/news/218433/immunoprecise-antibodies-recruits-pharma-exec-andy-nixon-to-board-218433.html ImmunoPrecise and TetraGenetics extend alliance to discover therapeutic antibodies for autoimmune disease https://www.proactiveinvestors.com/companies/news/218262/immunoprecise-and-tetragenetics-extend-alliance-to-discover-therapeutic-antibodies-for-autoimmune-disease-218262.html Tue, 09 Apr 2019 16:03:00 -0400 https://www.proactiveinvestors.com/companies/news/218262/immunoprecise-and-tetragenetics-extend-alliance-to-discover-therapeutic-antibodies-for-autoimmune-disease-218262.html ImmunoPrecise Antibodies forms new antibody discovery subsidiary Talem Therapeutics https://www.proactiveinvestors.com/companies/news/217980/immunoprecise-antibodies-forms-new-antibody-discovery-subsidiary-talem-therapeutics-217980.html Thu, 04 Apr 2019 13:46:00 -0400 https://www.proactiveinvestors.com/companies/news/217980/immunoprecise-antibodies-forms-new-antibody-discovery-subsidiary-talem-therapeutics-217980.html ImmunoPrecise Antibodies Ltd uplists to OTCQB Venture market from Pink Sheets https://www.proactiveinvestors.com/companies/news/217970/immunoprecise-antibodies-ltd-uplists-to-otcqb-venture-market-from-pink-sheets-217970.html Thu, 04 Apr 2019 12:06:00 -0400 https://www.proactiveinvestors.com/companies/news/217970/immunoprecise-antibodies-ltd-uplists-to-otcqb-venture-market-from-pink-sheets-217970.html ImmunoPrecise Antibodies on an aggressive sales and business development drive https://www.proactiveinvestors.com/companies/news/312839/immunoprecise-antibodies-on-an-aggressive-sales-and-business-development-drive-12839.html Tue, 02 Apr 2019 18:43:00 -0400 https://www.proactiveinvestors.com/companies/news/312839/immunoprecise-antibodies-on-an-aggressive-sales-and-business-development-drive-12839.html ImmunoPrecise Antibodies shares up as it launches new antibody discovery platform with US pharma group https://www.proactiveinvestors.com/companies/news/217789/immunoprecise-antibodies-shares-up-as-it-launches-new-antibody-discovery-platform-with-us-pharma-group-217789.html Tue, 02 Apr 2019 10:58:00 -0400 https://www.proactiveinvestors.com/companies/news/217789/immunoprecise-antibodies-shares-up-as-it-launches-new-antibody-discovery-platform-with-us-pharma-group-217789.html ImmunoPrecise Antibodies sees 56% increase in 3Q revenue as it continues to advance business https://www.proactiveinvestors.com/companies/news/217425/immunoprecise-antibodies-sees-56-increase-in-3q-revenue-as-it-continues-to-advance-business-217425.html Thu, 28 Mar 2019 12:26:00 -0400 https://www.proactiveinvestors.com/companies/news/217425/immunoprecise-antibodies-sees-56-increase-in-3q-revenue-as-it-continues-to-advance-business-217425.html ImmunoPrecise says ModiQuest managing director leaving to take CEO role https://www.proactiveinvestors.com/companies/news/216583/immunoprecise-says-modiquest-managing-director-leaving-to-take-ceo-role-216583.html Fri, 15 Mar 2019 19:30:00 -0400 https://www.proactiveinvestors.com/companies/news/216583/immunoprecise-says-modiquest-managing-director-leaving-to-take-ceo-role-216583.html Immunoprecise shares now eligible for electronic clearing and settlement in the US https://www.proactiveinvestors.com/companies/news/215552/immunoprecise-shares-now-eligible-for-electronic-clearing-and-settlement-in-the-us-215552.html Thu, 28 Feb 2019 16:40:00 -0500 https://www.proactiveinvestors.com/companies/news/215552/immunoprecise-shares-now-eligible-for-electronic-clearing-and-settlement-in-the-us-215552.html ImmunoPrecise Antibodies clinches contract from Leidos Biomedical Research https://www.proactiveinvestors.com/companies/news/215067/immunoprecise-antibodies-clinches-contract-from-leidos-biomedical-research-215067.html Thu, 21 Feb 2019 15:13:00 -0500 https://www.proactiveinvestors.com/companies/news/215067/immunoprecise-antibodies-clinches-contract-from-leidos-biomedical-research-215067.html ImmunoPrecise Antibodies collaborates with FIND to advance new tuberculosis diagnostic test https://www.proactiveinvestors.com/companies/news/214897/immunoprecise-antibodies-collaborates-with-find-to-advance-new-tuberculosis-diagnostic-test-214897.html Tue, 19 Feb 2019 15:07:00 -0500 https://www.proactiveinvestors.com/companies/news/214897/immunoprecise-antibodies-collaborates-with-find-to-advance-new-tuberculosis-diagnostic-test-214897.html ImmunoPrecise Antibodies opens new office in Cambridge, MA https://www.proactiveinvestors.com/companies/news/214657/immunoprecise-antibodies-opens-new-office-in-cambridge-ma-214657.html Thu, 14 Feb 2019 15:04:00 -0500 https://www.proactiveinvestors.com/companies/news/214657/immunoprecise-antibodies-opens-new-office-in-cambridge-ma-214657.html ImmunoPrecise boosts screening capability with lab equipment purchase https://www.proactiveinvestors.com/companies/news/214014/immunoprecise-boosts-screening-capability-with-lab-equipment-purchase-214014.html Tue, 05 Feb 2019 14:55:00 -0500 https://www.proactiveinvestors.com/companies/news/214014/immunoprecise-boosts-screening-capability-with-lab-equipment-purchase-214014.html ImmunoPrecise Antibodies appoints Lisa Helbling as chief financial officer https://www.proactiveinvestors.com/companies/news/212529/immunoprecise-antibodies-appoints-lisa-helbling-as-chief-financial-officer-212529.html Mon, 14 Jan 2019 17:03:00 -0500 https://www.proactiveinvestors.com/companies/news/212529/immunoprecise-antibodies-appoints-lisa-helbling-as-chief-financial-officer-212529.html Immunoprecise Antibodies reports 2Q revenue doubled on increased capacity, European expansion https://www.proactiveinvestors.com/companies/news/211853/immunoprecise-antibodies-reports-2q-revenue-doubled-on-increased-capacity-european-expansion-211853.html Wed, 02 Jan 2019 13:20:00 -0500 https://www.proactiveinvestors.com/companies/news/211853/immunoprecise-antibodies-reports-2q-revenue-doubled-on-increased-capacity-european-expansion-211853.html ImmunoPrecise Antibodies hires Jason Orloske as vice president for operations https://www.proactiveinvestors.com/companies/news/211730/immunoprecise-antibodies-hires-jason-orloske-as-vice-president-for-operations-211730.html Wed, 26 Dec 2018 14:45:00 -0500 https://www.proactiveinvestors.com/companies/news/211730/immunoprecise-antibodies-hires-jason-orloske-as-vice-president-for-operations-211730.html Immunoprecise Antibodies expanding immunization services through recent growth in Europe https://www.proactiveinvestors.com/companies/news/208058/immunoprecise-antibodies-expanding-immunization-services-through-recent-growth-in-europe-208058.html Mon, 29 Oct 2018 18:40:00 -0400 https://www.proactiveinvestors.com/companies/news/208058/immunoprecise-antibodies-expanding-immunization-services-through-recent-growth-in-europe-208058.html Immunoprecise Antibodies' ModiQuest to offer OmniAb service in Europe too https://www.proactiveinvestors.com/companies/news/207117/immunoprecise-antibodies-modiquest-to-offer-omniab-service-in-europe-too-207117.html Mon, 15 Oct 2018 18:17:00 -0400 https://www.proactiveinvestors.com/companies/news/207117/immunoprecise-antibodies-modiquest-to-offer-omniab-service-in-europe-too-207117.html Immunoprecise Antibodies bolstered as it inks development deal with top 15 global pharma firm https://www.proactiveinvestors.com/companies/news/206714/immunoprecise-antibodies-bolstered-as-it-inks-development-deal-with-top-15-global-pharma-firm-206714.html Tue, 09 Oct 2018 17:32:00 -0400 https://www.proactiveinvestors.com/companies/news/206714/immunoprecise-antibodies-bolstered-as-it-inks-development-deal-with-top-15-global-pharma-firm-206714.html Immunoprecise Antibodies adds new platforms to its range of services https://www.proactiveinvestors.com/companies/news/206224/immunoprecise-antibodies-adds-new-platforms-to-its-range-of-services-206224.html Tue, 02 Oct 2018 17:46:00 -0400 https://www.proactiveinvestors.com/companies/news/206224/immunoprecise-antibodies-adds-new-platforms-to-its-range-of-services-206224.html Immunoprecise Antibodies reports strong increase in revenue for first quarter https://www.proactiveinvestors.com/companies/news/206131/immunoprecise-antibodies-reports-strong-increase-in-revenue-for-first-quarter-206131.html Mon, 01 Oct 2018 18:43:00 -0400 https://www.proactiveinvestors.com/companies/news/206131/immunoprecise-antibodies-reports-strong-increase-in-revenue-for-first-quarter-206131.html ImmunoPrecise Antibodies brings in $9mln to further advance the business at home and abroad https://www.proactiveinvestors.com/companies/news/206020/immunoprecise-antibodies-brings-in-9mln-to-further-advance-the-business-at-home-and-abroad-206020.html Fri, 28 Sep 2018 15:49:00 -0400 https://www.proactiveinvestors.com/companies/news/206020/immunoprecise-antibodies-brings-in-9mln-to-further-advance-the-business-at-home-and-abroad-206020.html Immunoprecise Antibodies brings in over $9M from oversubscribed placing to expand operations https://www.proactiveinvestors.com/companies/news/205993/immunoprecise-antibodies-brings-in-over-9m-from-oversubscribed-placing-to-expand-operations-205993.html Fri, 28 Sep 2018 13:18:00 -0400 https://www.proactiveinvestors.com/companies/news/205993/immunoprecise-antibodies-brings-in-over-9m-from-oversubscribed-placing-to-expand-operations-205993.html Immunoprecise Antibodies' Dr Dryhurst picked for Canada life sciences leadership program https://www.proactiveinvestors.com/companies/news/205471/immunoprecise-antibodies-dr-dryhurst-picked-for-canada-life-sciences-leadership-program-205471.html Fri, 21 Sep 2018 17:50:00 -0400 https://www.proactiveinvestors.com/companies/news/205471/immunoprecise-antibodies-dr-dryhurst-picked-for-canada-life-sciences-leadership-program-205471.html Immunoprecise Antibodies partners with Harbour Antibodies to provide industry-leading discovery solution https://www.proactiveinvestors.com/companies/news/203913/immunoprecise-antibodies-partners-with-harbour-antibodies-to-provide-industry-leading-discovery-solution-203913.html Thu, 30 Aug 2018 15:43:00 -0400 https://www.proactiveinvestors.com/companies/news/203913/immunoprecise-antibodies-partners-with-harbour-antibodies-to-provide-industry-leading-discovery-solution-203913.html Immunoprecise Antibodies posts record revenues in fiscal 2018, thanks to U-Protein and ModiQuest acquisitions https://www.proactiveinvestors.com/companies/news/203816/immunoprecise-antibodies-posts-record-revenues-in-fiscal-2018-thanks-to-u-protein-and-modiquest-acquisitions-203816.html Wed, 29 Aug 2018 14:47:00 -0400 https://www.proactiveinvestors.com/companies/news/203816/immunoprecise-antibodies-posts-record-revenues-in-fiscal-2018-thanks-to-u-protein-and-modiquest-acquisitions-203816.html Immunoprecise Antibodies set for C$2mln placing https://www.proactiveinvestors.com/companies/news/203486/immunoprecise-antibodies-set-for-c2mln-placing-203486.html Thu, 23 Aug 2018 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/203486/immunoprecise-antibodies-set-for-c2mln-placing-203486.html Immunoprecise Antibodies welcomes Champagne as advisory board member https://www.proactiveinvestors.com/companies/news/203309/immunoprecise-antibodies-welcomes-champagne-as-advisory-board-member-203309.html Tue, 21 Aug 2018 11:59:00 -0400 https://www.proactiveinvestors.com/companies/news/203309/immunoprecise-antibodies-welcomes-champagne-as-advisory-board-member-203309.html Immunoprecise Antibodies shares advance as it launches new facility ahead of schedule due to demand https://www.proactiveinvestors.com/companies/news/201085/immunoprecise-antibodies-shares-advance-as-it-launches-new-facility-ahead-of-schedule-due-to-demand-201085.html Wed, 18 Jul 2018 19:07:00 -0400 https://www.proactiveinvestors.com/companies/news/201085/immunoprecise-antibodies-shares-advance-as-it-launches-new-facility-ahead-of-schedule-due-to-demand-201085.html Immunoprecise Antibodies announces closure of C$700,000 private placement https://www.proactiveinvestors.com/companies/news/199168/immunoprecise-antibodies-announces-closure-of-c700000-private-placement-199168.html Tue, 19 Jun 2018 21:41:00 -0400 https://www.proactiveinvestors.com/companies/news/199168/immunoprecise-antibodies-announces-closure-of-c700000-private-placement-199168.html ImmunoPrecise Antibodies boosts private placement to $700,000; shares rise https://www.proactiveinvestors.com/companies/news/197962/immunoprecise-antibodies-boosts-private-placement-to-700000-shares-rise-197962.html Wed, 30 May 2018 20:41:00 -0400 https://www.proactiveinvestors.com/companies/news/197962/immunoprecise-antibodies-boosts-private-placement-to-700000-shares-rise-197962.html ImmunoPrecise Antibodies announces C$600,000 private placement https://www.proactiveinvestors.com/companies/news/197847/immunoprecise-antibodies-announces-c600000-private-placement-197847.html Tue, 29 May 2018 15:17:00 -0400 https://www.proactiveinvestors.com/companies/news/197847/immunoprecise-antibodies-announces-c600000-private-placement-197847.html ImmunoPrecise Antibodies adds Bath to board and expands senior leadership https://www.proactiveinvestors.com/companies/news/197741/immunoprecise-antibodies-adds-bath-to-board-and-expands-senior-leadership-197741.html Fri, 25 May 2018 16:08:00 -0400 https://www.proactiveinvestors.com/companies/news/197741/immunoprecise-antibodies-adds-bath-to-board-and-expands-senior-leadership-197741.html Immunoprecise Antibodies' new Fargo headquarters means it can take advantage of a diverse economy https://www.proactiveinvestors.com/companies/news/197301/immunoprecise-antibodies-new-fargo-headquarters-means-it-can-take-advantage-of-a-diverse-economy-197301.html Fri, 18 May 2018 19:03:00 -0400 https://www.proactiveinvestors.com/companies/news/197301/immunoprecise-antibodies-new-fargo-headquarters-means-it-can-take-advantage-of-a-diverse-economy-197301.html Immunoprecise Antibodies surges after opening new B-cell facility https://www.proactiveinvestors.com/companies/news/195995/immunoprecise-antibodies-surges-after-opening-new-b-cell-facility-195995.html Fri, 27 Apr 2018 17:36:00 -0400 https://www.proactiveinvestors.com/companies/news/195995/immunoprecise-antibodies-surges-after-opening-new-b-cell-facility-195995.html Immunoprecise Antibodies completes ModiQuest Research acquisition https://www.proactiveinvestors.com/companies/news/194560/immunoprecise-antibodies-completes-modiquest-research-acquisition-194560.html Fri, 06 Apr 2018 20:07:00 -0400 https://www.proactiveinvestors.com/companies/news/194560/immunoprecise-antibodies-completes-modiquest-research-acquisition-194560.html Immunoprecise Antibodies shares surge as it posts record revenue in third quarter https://www.proactiveinvestors.com/companies/news/194066/immunoprecise-antibodies-shares-surge-as-it-posts-record-revenue-in-third-quarter-194066.html Thu, 29 Mar 2018 19:38:00 -0400 https://www.proactiveinvestors.com/companies/news/194066/immunoprecise-antibodies-shares-surge-as-it-posts-record-revenue-in-third-quarter-194066.html ImmunoPrecise Antibodies acquires custom antibody generation specialist ModiQuest Research https://www.proactiveinvestors.com/companies/news/193326/immunoprecise-antibodies-acquires-custom-antibody-generation-specialist-modiquest-research-193326.html Fri, 16 Mar 2018 18:14:00 -0400 https://www.proactiveinvestors.com/companies/news/193326/immunoprecise-antibodies-acquires-custom-antibody-generation-specialist-modiquest-research-193326.html ImmunoPrecise Antibodies names Dr Jennifer Bath as new president and chief executive https://www.proactiveinvestors.com/companies/news/191400/immunoprecise-antibodies-names-dr-jennifer-bath-as-new-president-and-chief-executive-191400.html Thu, 08 Feb 2018 14:35:00 -0500 https://www.proactiveinvestors.com/companies/news/191400/immunoprecise-antibodies-names-dr-jennifer-bath-as-new-president-and-chief-executive-191400.html ImmunoPrecise Antibodies makes US$5mln strategic investment in Single Cell Technology Inc https://www.proactiveinvestors.com/companies/news/190414/immunoprecise-antibodies-makes-us5mln-strategic-investment-in-single-cell-technology-inc-190414.html Mon, 22 Jan 2018 20:21:00 -0500 https://www.proactiveinvestors.com/companies/news/190414/immunoprecise-antibodies-makes-us5mln-strategic-investment-in-single-cell-technology-inc-190414.html ImmunoPrecise Antibodies hires LightPath Capital as key partner in its financing strategy https://www.proactiveinvestors.com/companies/news/190265/immunoprecise-antibodies-hires-lightpath-capital-as-key-partner-in-its-financing-strategy-190265.html Thu, 18 Jan 2018 19:01:00 -0500 https://www.proactiveinvestors.com/companies/news/190265/immunoprecise-antibodies-hires-lightpath-capital-as-key-partner-in-its-financing-strategy-190265.html ImmunoPrecise Antibodies reports 65% revenue rise in second quarter as it continues global acquisition strategy https://www.proactiveinvestors.com/companies/news/189414/immunoprecise-antibodies-reports-65-revenue-rise-in-second-quarter-as-it-continues-global-acquisition-strategy-189414.html Tue, 02 Jan 2018 17:18:00 -0500 https://www.proactiveinvestors.com/companies/news/189414/immunoprecise-antibodies-reports-65-revenue-rise-in-second-quarter-as-it-continues-global-acquisition-strategy-189414.html ImmunoPrecise Antibodies set to buy Germany based Preclinics GmbH in C$3.45mln deal; shares surge https://www.proactiveinvestors.com/companies/news/189347/immunoprecise-antibodies-set-to-buy-germany-based-preclinics-gmbh-in-c345mln-deal-shares-surge-189347.html Fri, 29 Dec 2017 21:03:00 -0500 https://www.proactiveinvestors.com/companies/news/189347/immunoprecise-antibodies-set-to-buy-germany-based-preclinics-gmbh-in-c345mln-deal-shares-surge-189347.html ImmunoPrecise Antibodies lines up acquisition of Dutch biotech https://www.proactiveinvestors.com/companies/news/189263/immunoprecise-antibodies-lines-up-acquisition-of-dutch-biotech-189263.html Fri, 22 Dec 2017 21:11:00 -0500 https://www.proactiveinvestors.com/companies/news/189263/immunoprecise-antibodies-lines-up-acquisition-of-dutch-biotech-189263.html ImmunoPrecise Antibodies adds scientific depth to board with new director https://www.proactiveinvestors.com/companies/news/189037/immunoprecise-antibodies-adds-scientific-depth-to-board-with-new-director-189037.html Tue, 19 Dec 2017 16:03:00 -0500 https://www.proactiveinvestors.com/companies/news/189037/immunoprecise-antibodies-adds-scientific-depth-to-board-with-new-director-189037.html ImmunoPrecise Antibodies' chairman sets out ambitious growth plans after it wraps up its latest deal https://www.proactiveinvestors.com/companies/news/188595/immunoprecise-antibodies-chairman-sets-out-ambitious-growth-plans-after-it-wraps-up-its-latest-deal-188595.html Mon, 11 Dec 2017 14:16:00 -0500 https://www.proactiveinvestors.com/companies/news/188595/immunoprecise-antibodies-chairman-sets-out-ambitious-growth-plans-after-it-wraps-up-its-latest-deal-188595.html ImmunoPrecise Antibodies set to buy ModiQuest in C$10.5mln deal https://www.proactiveinvestors.com/companies/news/188461/immunoprecise-antibodies-set-to-buy-modiquest-in-c105mln-deal-188461.html Thu, 07 Dec 2017 14:50:00 -0500 https://www.proactiveinvestors.com/companies/news/188461/immunoprecise-antibodies-set-to-buy-modiquest-in-c105mln-deal-188461.html